International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8098533
Original Article
Evaluation of Spirometric Profile of Post-Pulmonary Tuberculosis Patients Attending In the Department of Respiratory Medicine in Agmc and Gbp Hospital
 ,
 ,
 ,
 ,
Published
June 30, 2023
Abstract

Background: Tuberculosis, the disease caused by Mycobacterium tuberculosis, is recognized as a global public health problem. Post Tuberculosis sequelae are the anatomical and pathophysiological changes in the respiratory system which occurs secondary to complications of pulmonary TB, whether primary or secondary, even after completion of treatment and complete bacteriological cure. Accurate estimates of the frequency and the extent of the pulmonary impairment from tuberculosis are important to patients and clinicians. Hence, it is necessary to assess the extent of the pulmonary function abnormalities among patient who have successfully completed the treatment for pulmonary tuberculosis.

Objectives: To assess the type and grade of airway obstruction in patients who are successfully treated for pulmonary tuberculosis attending Respiratory Medicine department.

Methodology: Cross-sectional hospital based observational study was conducted for a period of one and a half years between February 2021 to July2022 in a tertiary care at Agartala Tripura. All the patients with past history of treated tuberculosis attending in the Department of Respiratory Medicine (OPD & IPD), Agartala Govt. Medical College & G.B.P. Hospital from February 2021 to July 2022 were included in the study fulfilling inclusion and exclusion criteria. During this period spirometry was performed among 152 patients.

Results: The study found that the predominant residual respiratory symptom was shortness of breath (146; 96.1%). This was followed in a descending order by cough (108; 71.1%), haemoptysis (23; 15.1%) and chest pain (58; 38.2%). Among 152 cases, 109 cases were found to have abnormal spirometric patterns. Different age group distribution between 32 different spirometric pattern was not significant (p>0.05). The different spirometric pattern found was involving 67 (44.08%) with obstructive pattern, 27(17.76%) with restrictive pattern, 15(9.87%) with mixed pattern and normal patterns found in 43(28.29%) patients. Majority of the patients 43 cases (64.18%) with obstructive spirometric pattern had severe obstruction. 4 (5.97%) cases had mild obstruction; 20(29.85%) cases had moderate obstruction. Among the recruited patients with abnormal spirometric pattern, 22(20.18%) cases showed significant bronchodilator reversibility (BDR) response and 87(79.82%) cases showed non-significant bronchodilator reversibility response.

Conclusion: The study found that pulmonary tuberculosis irrespective of duration of treatment and outcome of the disease does not correlate with the pulmonary function. It was also found that many of the post-pulmonary tuberculosis patients have persistent respiratory symptoms with obstructive lung disease being the most predominant lung function impairment.

Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2225 Views
40 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved